OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)

OPTUS Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17,085	26,906	17,811	10,409	32,555	42,423
Short-Term Investments	24,000	24,000	40,000	40,000	42,000	39,973
Trading Asset Securities	500.7	502.41	10,711	11,146	-	-
Cash & Short-Term Investments	41,586	51,408	68,522	61,555	74,555	82,395
Cash Growth	-35.96%	-24.98%	11.32%	-17.44%	-9.52%	19.14%
Accounts Receivable	11,583	13,492	9,321	7,472	6,313	3,875
Other Receivables	682.47	231.04	632.99	418.49	223.12	208.61
Receivables	12,291	13,753	9,995	7,908	6,564	4,108
Inventory	15,034	12,500	13,071	11,622	9,791	6,748
Prepaid Expenses	94.02	172.83	137.33	83.78	105.4	65.87
Other Current Assets	934.42	61.71	46.08	217.78	1	113.44
Total Current Assets	69,939	77,896	91,772	81,386	91,017	93,431
Property, Plant & Equipment	58,640	56,863	42,501	43,735	38,717	28,267
Long-Term Investments	13,791	13,740	13,497	10,121	9,636	8,127
Other Intangible Assets	15,954	16,066	-	-	-	-
Long-Term Accounts Receivable	-0	-	-	-	-0	-0
Long-Term Deferred Tax Assets	-	-	-	-	614.46	-
Other Long-Term Assets	1,860	1,928	1,647	963.78	53.31	71.77
Total Assets	160,185	166,503	149,460	136,240	140,038	129,897
Accounts Payable	1,609	3,124	1,889	1,536	1,519	1,213
Accrued Expenses	3,647	5,638	7,976	5,804	4,885	3,908
Current Portion of Leases	678.7	694.79	713.48	680.29	73.11	108.03
Current Income Taxes Payable	375.97	423.89	1,147	289.1	1,197	1,283
Other Current Liabilities	7,275	11,229	1,347	1,450	3,701	2,070
Total Current Liabilities	13,586	21,110	13,072	9,760	11,375	8,582
Long-Term Leases	579.64	758.87	1,359	1,918	167.1	352.32
Long-Term Deferred Tax Liabilities	774.12	738.22	494.15	14.92	-	828.05
Other Long-Term Liabilities	167.98	161.73	83.75	79.51	0	-
Total Liabilities	15,108	22,768	15,009	11,773	13,018	11,014
Common Stock	8,282	8,282	8,282	8,282	8,282	8,282
Additional Paid-In Capital	36,587	36,601	36,553	36,663	36,663	36,663
Retained Earnings	105,151	103,978	95,689	86,636	85,281	77,034
Treasury Stock	-5,580	-5,580	-5,751	-6,352	-3,068	-3,068
Comprehensive Income & Other	637.6	453.44	-322.28	-762.48	-137.35	-28.86
Shareholders' Equity	145,078	143,735	134,451	124,467	127,021	118,883
Total Liabilities & Equity	160,185	166,503	149,460	136,240	140,038	129,897
Total Debt	1,258	1,454	2,073	2,598	240.2	460.35
Net Cash (Debt)	40,328	49,955	66,450	58,956	74,315	81,935
Net Cash Growth	-36.03%	-24.82%	12.71%	-20.67%	-9.30%	18.78%
Net Cash Per Share	2641.47	3271.01	4372.19	3717.14	4635.53	5079.34
Filing Date Shares Outstanding	15.29	15.29	15.26	15.17	16.04	16.04
Total Common Shares Outstanding	15.29	15.29	15.26	15.17	16.04	16.04
Working Capital	56,354	56,787	78,700	71,626	79,642	84,849
Book Value Per Share	9490.96	9403.11	8811.11	8207.04	7918.38	7411.07
Tangible Book Value	129,123	127,669	134,451	124,467	127,021	118,883
Tangible Book Value Per Share	8447.23	8352.11	8811.11	8207.04	7918.38	7411.07
Land	5,271	5,271	5,271	5,478	5,584	5,584
Buildings	19,106	19,266	19,188	19,938	16,130	13,534
Machinery	11,706	12,099	13,415	14,420	4,577	5,406
Construction In Progress	20,951	18,412	1,999	506.56	12,183	3,291

Source: S&P Global Market Intelligence. Standard template. Financial Sources.